Single Pass
Lake Forest
About Single Pass
Single Pass is a developer of a disposable bipolar electrocautery device that can cauterize deep tissue through a guide needle.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $460.0K
- Funding stage: Seed
- Last round: Seed (Aug 2022)
- Website: singlepass.co
Industries & Categories
Life Science, Medical
Canonical: https://fsome.com/organization/single-pass-25924 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.